Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
|3||Not yet recruiting||
Phase III Open Label First Line Therapy Study of MEDI 4736 With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).
† Indicates status has not been verified in more than two years